Página principal > Resultados de la búsqueda: Ilson, David H.
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Resultados globales: 2 registros encontrados en 0.03 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
10 p, 384.2 KB Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy / Ilson, David H. (Memorial Sloan Kettering Cancer Center (Estats Units d'Amèrica)) ; Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ; Prokharau, Aliaksandr (Minsk City Clinical Oncology Dispensary) ; Arkenau, Hendrik-Tobias (University College London) ; Ghidini, Michele (Azienda Ospedaliera di Cremona) ; Fujitani, Kazumasa (Osaka General Medical Center) ; Van Cutsem, Eric (University Hospitals Gasthuisberg (Leuven, Bélgica)) ; Thuss-Patience, Peter (Charité - Universitätsmedizin Berlin) ; Beretta, Giordano D. (Humanitas Gavazzeni) ; Mansoor, Wasat (The Christie NHS Foundation Trust (Regne Unit)) ; Zhavrid, Edvard (Alexandrov National Cancer Centre of Belarus) ; Alsina, Maria (Vall d'Hebron Institut d'Oncologia) ; George, Ben (Medical College of Wisconsin) ; Catenacci, Daniel (University of Chicago) ; McGuigan, Sandra (Taiho Oncology Inc) ; Makris, Lukas (Stathmi Inc) ; Doi, Toshihiko (National Cancer Center Hospital East (Japó)) ; Shitara, Kohei (National Cancer Center Hospital East (Japó)) ; Universitat Autònoma de Barcelona
This subgroup analysis of a randomized clinical trial compares trifluridine/tipiracil treatment with placebo for progression-free and overall survival among patients with previously treated metastatic gastric or gastroesophageal junction cancer who had or had not undergone gastrectomy. [...]
2019 - 10.1001/jamaoncol.2019.3531
JAMA Oncology, Vol. 6 (october 2019)  
Registro completo - Creative Commons
2.
8 p, 1.6 MB Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer : a subgroup analysis from the phase 3 TAGS study / Mansoor, Wasat (The Christie NHS Foundation Trust) ; Arkenau, Hendrik-Tobias (University College London) ; Alsina, Maria (Vall d'Hebron Institut d'Oncologia) ; Shitara, Kohei (National Cancer Center Hospital East) ; Thuss-Patience, Peter (Charité - Universitätsmedizin Berlin) ; Cuffe, Sinead (St. James's Hospital ( Dublín, Irlanda)) ; Dvorkin, Mikhail (Omsk Regional Clinical Centre of Oncology) ; Park, David (St, Joseph Heritage Healthcare) ; Ando, Takayuki (University of Toyama) ; Van Den Eynde, Marc (UCL Cliniques Universitaires Saint-Luc) ; Beretta, Giordano D. (Humanitas Gavazzeni) ; Zaniboni, Alberto (Fondazione Poliambulanza-Istituto Ospedaliero) ; Doi, Toshihiko (National Cancer Center Hospital East) ; Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ; Ilson, David H. (Memorial Sloan Kettering Cancer Center) ; Makris, Lukas (Stathmi, Inc, New Hope, PA USA) ; Benhadji, Karim A. (Taiho Oncology) ; Van Cutsem, Eric (University Hospitals Gasthuisberg (Leuven, Bélgica)) ; Universitat Autònoma de Barcelona
Patients with advanced gastroesophageal junction cancer (GEJC) have poor survival outcomes, and GEJC-specific data from trials evaluating agents in gastric cancers (GCs) as a whole are lacking. Trifluridine/tipiracil (FTD/TPI) was approved for previously treated metastatic GC or GEJC (mGC/mGEJC) based on results of the phase 3 TAGS trial. [...]
2021 - 10.1007/s10120-021-01156-x
Gastric Cancer, Vol. 24 (march 2021) , p. 970-977  
Registro completo - Creative Commons

Vea también: autores con nombres similares
1 Ilson, D.H.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos